News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Arcturus Therapeutics and CSL's ARCT-154 COVID-19 Vaccine Application for Marketing Authorization Receives Validation From European Medicines Agency
Wednesday, September 06, 2023Arcturus Therapeutics Holdings Inc Nasdaq ARCT is a global biopharmaceutical company specializing in the development of messenger RNA mRNA medicines CSL ASX CSL a leading provider of influenza vaccines operates through its vaccine business CSL Seqiru...
Inmune Bio Inc. Receives Approval From the U.K. Medicines and Healthcare Products Regulatory Agency for Phase 2 Clinical Trial in Alzheimer's Disease
Wednesday, September 06, 2023INmune Bio Inc NASDAQ INMB a clinicalstage immunology company dedicated to developing treatments that harness the innate immune system to combat diseases has received approval from the Medicines and Healthcare products Regulatory Agency MHRA to initi...
Esocap Achieves Full Patient Enrollment in Phase II ACESO Trial for Eosinophilic Esophagitis
Tuesday, September 05, 2023Swiss biotech company EsoCap AG has announced the successful completion of patient recruitment for the Phase II ACESO trial This study is a randomized placebocontrolled doubleblind investigation into the efficacy tolerability and safety of their prod...
Invios Commences Additional Clinical Trial for APN401, an Innovative Cell Therapy for Solid Tumors, and Secures Substantial Research Grant From Austria
Tuesday, September 05, 2023InvIOs GmbH a privately owned biotechnology firm dedicated to pioneering cancer therapies has initiated the recruitment of patients for a Phase b clinical trial of its innovative autologous cell therapy APN This trial aims to enroll patients with sol...
Advancements in Dipraglurant Research for Post-stroke Recovery by Addex Supported by Findings in Brain Journal
Monday, September 04, 2023Addex Therapeutics SIX and Nasdaq ADXN a clinicalstage pharmaceutical company specializing in allosteric modulationbased drug discovery and development has disclosed new findings published in the journal Brain
Elastin Biosciences Announces a Significant Breakthrough in the Restoration of Elastin, Opening New Avenues for Treating Elastin-Deficiency Disorders
Saturday, September 02, 2023Longaevus Technologies is excited to announce the establishment of Elastin Biosciences as an independent entity following the remarkable preclinical results achieved by three of its research programs
First Patient With Chronic Hepatitis B Receives Initial Dose of ISA104 in Phase 1 Clinical Study
Friday, September 01, 2023ISA Pharmaceuticals BV a clinicalstage biotech firm dedicated to developing novel immunotherapies for cancer and serious infectious diseases has announced the initiation of the HEBPEP study
Ai Therapeutics Initiates Phase 2 Clinical Trial to Evaluate LAM-001 for Pulmonary Arterial Hypertension (PAH) Treatment
Friday, September 01, 2023AI Therapeutics a clinicalstage biopharmaceutical company specializing in rare disease therapeutics has unveiled the initiation of a Phase study for LAM its innovative inhaled form of sirolimus This development aims to address pulmonary arterial hyp...
Relief Therapeutics and Acer Therapeutics Forge Exclusive License Agreement for OLPRUVA™ (ACER-001)
Thursday, August 31, 2023RELIEF THERAPEUTICS Holding SA SWXRLF has recently entered into an exclusive licensing agreement with Acer Therapeutics Inc for the development and commercialization of OLPRUVA sodium phenylbutyrate
European Commission Grants Approval to Roche's Evrysdi for Infants Under Two Months Old With Spinal Muscular Atrophy (SMA)
Wednesday, August 30, 2023Roche SIX RO ROG OTCQX RHHBY has received approval from the European Commission to expand the use of Evrysdi risdiplam within the European Union EU
